These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 9013973)
21. Thrombopoietin stimulates endothelial cell motility and neoangiogenesis by a platelet-activating factor-dependent mechanism. Brizzi MF; Battaglia E; Montrucchio G; Dentelli P; Del Sorbo L; Garbarino G; Pegoraro L; Camussi G Circ Res; 1999 Apr; 84(7):785-96. PubMed ID: 10205146 [TBL] [Abstract][Full Text] [Related]
22. Role of tumor necrosis factor-alpha and platelet-activating factor in neoangiogenesis induced by synovial fluids of patients with rheumatoid arthritis. Lupia E; Montrucchio G; Battaglia E; Modena V; Camussi G Eur J Immunol; 1996 Aug; 26(8):1690-4. PubMed ID: 8765007 [TBL] [Abstract][Full Text] [Related]
23. Triple role of platelet-activating factor in eosinophil migration across monolayers of lung epithelial cells: eosinophil chemoattractant and priming agent and epithelial cell activator. Liu L; Zuurbier AE; Mul FP; Verhoeven AJ; Lutter R; Knol EF; Roos D J Immunol; 1998 Sep; 161(6):3064-70. PubMed ID: 9743372 [TBL] [Abstract][Full Text] [Related]
24. Autocrine/paracrine involvement of platelet-activating factor and transforming growth factor-beta in the induction of phosphatidylserine recognition by murine macrophages. Rose DM; Fadok VA; Riches DW; Clay KL; Henson PM J Immunol; 1995 Dec; 155(12):5819-25. PubMed ID: 7499871 [TBL] [Abstract][Full Text] [Related]
25. Platelet-activating factor enhances vascular endothelial growth factor-induced endothelial cell motility and neoangiogenesis in a murine matrigel model. Montrucchio G; Lupia E; Battaglia E; Del Sorbo L; Boccellino M; Biancone L; Emanuelli G; Camussi G Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):80-8. PubMed ID: 10634803 [TBL] [Abstract][Full Text] [Related]
26. Platelet-activating factor directly stimulates in vitro migration of endothelial cells and promotes in vivo angiogenesis by a heparin-dependent mechanism. Camussi G; Montrucchio G; Lupia E; De Martino A; Perona L; Arese M; Vercellone A; Toniolo A; Bussolino F J Immunol; 1995 Jun; 154(12):6492-501. PubMed ID: 7539022 [TBL] [Abstract][Full Text] [Related]
27. Platelet-activating factor triggers the phosphorylation and activation of MAP-2 kinase and S6 peptide kinase activity in human B cell lines. Franklin RA; Mazer B; Sawami H; Mills GB; Terada N; Lucas JJ; Gelfand EW J Immunol; 1993 Aug; 151(4):1802-10. PubMed ID: 7688385 [TBL] [Abstract][Full Text] [Related]
28. The hepatocyte growth factor and its receptor. Galimi F; Brizzi MF; Comoglio PM Stem Cells; 1993 Jul; 11 Suppl 2():22-30. PubMed ID: 8401259 [TBL] [Abstract][Full Text] [Related]
29. Increased platelet-activating factor receptor gene expression by corneal epithelial wound healing. Ma X; Bazan HE Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1696-702. PubMed ID: 10845588 [TBL] [Abstract][Full Text] [Related]
30. Antagonistic effect of NK4, a novel hepatocyte growth factor variant, on in vitro angiogenesis of human vascular endothelial cells. Jiang WG; Hiscox SE; Parr C; Martin TA; Matsumoto K; Nakamura T; Mansel RE Clin Cancer Res; 1999 Nov; 5(11):3695-703. PubMed ID: 10589789 [TBL] [Abstract][Full Text] [Related]
31. Phagocytosis of apoptotic and necrotic thymocytes is inhibited by PAF-receptor antagonists and affects LPS-induced COX-2 expression in murine macrophages. de Oliveira SI; Fernandes PD; Amarante Mendes JG; Jancar S Prostaglandins Other Lipid Mediat; 2006 Jul; 80(1-2):62-73. PubMed ID: 16846787 [TBL] [Abstract][Full Text] [Related]
32. Tumor necrosis factor alpha-induced angiogenesis depends on in situ platelet-activating factor biosynthesis. Montrucchio G; Lupia E; Battaglia E; Passerini G; Bussolino F; Emanuelli G; Camussi G J Exp Med; 1994 Jul; 180(1):377-82. PubMed ID: 7516414 [TBL] [Abstract][Full Text] [Related]
33. Differences in platelet-activating factor receptor mediated Ca++ response between hamster and guinea pig alveolar macrophages. Chen J; Giri SN J Pharmacol Exp Ther; 1997 Jun; 281(3):1047-58. PubMed ID: 9190835 [TBL] [Abstract][Full Text] [Related]
34. Adaptor molecule Crk is required for sustained phosphorylation of Grb2-associated binder 1 and hepatocyte growth factor-induced cell motility of human synovial sarcoma cell lines. Watanabe T; Tsuda M; Makino Y; Ichihara S; Sawa H; Minami A; Mochizuki N; Nagashima K; Tanaka S Mol Cancer Res; 2006 Jul; 4(7):499-510. PubMed ID: 16849525 [TBL] [Abstract][Full Text] [Related]
35. PAF produced by human breast cancer cells promotes migration and proliferation of tumor cells and neo-angiogenesis. Bussolati B; Biancone L; Cassoni P; Russo S; Rola-Pleszczynski M; Montrucchio G; Camussi G Am J Pathol; 2000 Nov; 157(5):1713-25. PubMed ID: 11073830 [TBL] [Abstract][Full Text] [Related]
36. Alteration of platelet-activating factor-induced signal transduction in macrophages by n-3 fatty acids. Chakrabarti R; Hubbard NE; Lim D; Erickson KL Cell Immunol; 1997 Jan; 175(1):76-84. PubMed ID: 9015191 [TBL] [Abstract][Full Text] [Related]
37. Biochemical and pharmacological properties of SR 27388, a dual antioxidant and PAF receptor antagonist. Herbert JM; Fraisse L; Bachy A; Valette G; Savi P; Laplace MC; Lassalle J; Roche B; Lale A; Keane PE J Lipid Mediat; 1993 Aug; 8(1):31-51. PubMed ID: 8257776 [TBL] [Abstract][Full Text] [Related]
38. Hepatocyte growth factor (HGF)-induced cell migration is negatively modulated by epidermal growth factor through tyrosine phosphorylation of the HGF receptor. Takeuchi K; Shibamoto S; Hayakawa M; Hori T; Miyazawa K; Kitamura N; Ito F Exp Cell Res; 1996 Mar; 223(2):420-5. PubMed ID: 8601419 [TBL] [Abstract][Full Text] [Related]
39. Vascular endothelial growth factor-B promotes in vivo angiogenesis. Silvestre JS; Tamarat R; Ebrahimian TG; Le-Roux A; Clergue M; Emmanuel F; Duriez M; Schwartz B; Branellec D; Lévy BI Circ Res; 2003 Jul; 93(2):114-23. PubMed ID: 12805240 [TBL] [Abstract][Full Text] [Related]